THROMBOTIC RISK SCREEN
Rs 21,038 Rs 15,700
25 % OFF
A Thrombotic Risk Screen is a blood test designed to identify individuals at increased risk of developing blood clots. It assesses various factors, including genetic mutations, protein levels, and antibodies, that can contribute to abnormal blood clotting. This screening helps healthcare providers identify individuals who may benefit from preventive measures or closer monitoring to reduce their risk of serious clotting events like deep vein thrombosis or pulmonary embolism.
Included Tests
PROTEIN C ACTIVITY IS A BLOOD TEST THAT MEASURES THE FUNCTIONALITY OF PROTEIN C, A NATURAL ANTICOAGULANT IN THE BODY THAT HELPS PREVENT EXCESSIVE BLOOD CLOTTING. LOW PROTEIN C ACTIVITY INCREASES THE RISK OF DEVELOPING BLOOD CLOTS, SUCH AS DEEP VEIN THROMBOSIS (DVT) AND PULMONARY EMBOLISM. THIS TEST IS OFTEN ORDERED WHEN THERE IS A SUSPICION OF AN INCREASED CLOTTING RISK DUE TO FAMILY HISTORY, PREVIOUS BLOOD CLOTS, OR OTHER RISK FACTORS.
THIS ASSAY IS USED AS AN ADJUNCT TO INITIAL TESTING BASED ON THE RESULTS OF PROTEIN S ANTIGEN ASSAY. IT HELPS IN EVALUATING PATIENTS WITH HISTORY OF VENOUS THROMBOEMBOLISM AND DIAGNOSING CONGENITAL / ACQUIRED PROTEIN S DEFICIENCY. ONLY FREE PROTEIN S HAS ANTICOAGULANT ACTIVITY.
THIS ASSAY IS USED FOR EVALUATION OF PATIENTS WITH INCIDENT OR RECURRENT VENOUS THROMBOEMBOLISM, WITH FAMILY HISTORY OF VENOUS THROMBOEMBOLISM AND IN WOMEN WITH RECURRENT MISCARRIAGE OR COMPLICATIONS OF PREGNANCY. IT MAY ALSO BE USED FOR EVALUATING INDIVIDUALS WITH HISTORY OF ARTERIAL THROMBOSIS.
THIS TEST MEASURES THE FUNCTIONAL ACTIVITY OF ANTITHROMBIN, A PROTEIN THAT HELPS PREVENT BLOOD CLOTS. LOW ANTITHROMBIN ACTIVITY CAN INDICATE AN INCREASED RISK FOR THROMBOSIS (BLOOD CLOTS), SUCH AS DEEP VEIN THROMBOSIS (DVT) OR PULMONARY EMBOLISM (PE). IT CAN BE CAUSED BY A GENETIC DEFICIENCY, LIVER DISEASE, OR OTHER CONDITIONS.
Why book with us?
-
Free and On Schedule Sample Collection
-
24/7 Service
-
Affordable
-
Quick and Accurate Reports
6 mL whole blood in 2 Blue Top (Sodium Citrate) tubes. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 min. & finally transfer the supernatant (PPP) to 1 labelled clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. Overnight fasting is preferred. Duly filled . It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician.
Chromogenic, Immunoturbidimetry, Electromechanical Clot Detection
Overnight fasting is preferred. Duly filled . It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician.
